Get to Know: Chase Schwalbach, Chief Product Officer, FidoCure
Tell us about your background I grew up on the Ohio/Kentucky border, from a relatively modest background. My mom worked 3 jobs to support me and my 2 siblings, and I didn’t step onto a plane until I graduated college. I went to school at Morehead State University in Kentucky and got an undergraduate degree […]
Thrive Pet Healthcare and FidoCure® Announce An Expansive Pet Precision Health Partnership
Strategic partnership leveraging FidoCure’s precision medicine platform advances joint vision for providing personalized, accessible veterinary cancer care
Unique Perspective: Cancer Biologist & Pet Cancer Parent
Dr. Elizabeth Iorns is a scientist whose research focuses on identifying mechanisms of breast cancer progression. She is a cofounder and CEO of Science Exchange, and she helped launch the Reproducibility Initiative. She was involved in the development of Olaparib, a targeted therapy directed at the BRCA1 and BRCA2 mutation, best known for its relation […]
Targeted Therapy Efficacious Dose Finding: The Case for Agile Design
The following medical brief espouses how ordinary clinical trial design is rendered less than perfect for targeted therapies, and suggests how the following 3 interrelated Agile Trial Design principles should be considered:
Reflecting on 2020
Thank you for being on the front lines and taking such good care of your patients. We know it hasn’t been easy and we appreciate you. The pandemic upended our lives and how you practice veterinary medicine. Looking back, we’re extremely proud of our team, our community, and our industry for the way it has […]
Choosing Love and Compassion
What a week in our country. I can imagine that you may be feeling overwhelmed by the intensity of the news and pictures as I certainly am, as well as by the rapid pace of new information that keeps coming out.
Medical Brief: Sorafenib in Dogs
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs. By Laura Marconato, et al(Cancers (Basel). 2020 May 18;12(5):1272. doi: 10.3390/cancers12051272).
Medical Brief:The Median Isn’t the Message
Stephen J. Gould was one of the most influential authors of popular science. He was a paleontologist, evolutionary biologist and historian of science. The “Median Isn’t the Message” is an essay written by Stephen J. Gould in 1991 as part of his book Bully for Brontosaurus: Reflections in Natural History. The essay has been reprinted […]
Win-Win -The Development of Novel Immunotherapies for Brain Tumors Using Pet Dogs
On Thursday June 10th at 3pm EST/12pm PST, we were delighted to welcome Dr. Liz Pluhar to our webinar series. Dr. Pluhar is a full professor and small animal surgeon in the Department of Veterinary Clinical Sciences at the University of Minnesota and leads the Canine Brain Tumor Clinical Trials Program.
Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib
Jeylan Aslan, Michael A. Shipstone and Louise M. Sullivan Vet Dermatol. 2021 May 25. doi: 10.1111/vde.12976 This case study reviews the use of olacitinib to treat cutaneous epitheliotropic T-cell lymphoma (CETL).